The FDA now advises the non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided from the 20^th week of pregnancy due to the possible risk of oligohydramnios (unless under close medical supervision).

This advisory does not include low dose aspirin (81mg) when used for certain pregnancy-related conditions:

 Read the full FDA advisory here.